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Nature is an inexhaustible reservoir of compounds with heal-
ing properties, and people used natural products to treat dif-
ferent medical conditions from ancient times. One of the
main features of natural products is their ability to modulate
directly and indirectly oxidative stress and protect human
cells from aging and death [1]. Besides aging, cardiovascular
diseases, chronic obstructive pulmonary disease, chronic kid-
ney disease, and neurodegeneration, cancer can be consid-
ered as an oxidative stress-related disease [2]. Therefore,
natural products are also valuable for treating cancer.
Increased generation of reactive oxygen species (ROS) which
leads to oxidative stress and provokes inflammation eventu-
ally may cause carcinogenesis or stimulate cancer progres-
sion and metastatic behavior [3]. Despite still preserved
indigenous knowledge about plants and other organisms
with medicinal value, clinical development of natural prepa-
rations (both compounds and extracts) is difficult and slow.
However, some of the most exploited chemotherapeutics
have natural origin such as doxorubicin, vincristine, and pac-
litaxel [4]. Today, we know that natural compounds may also
cause unwanted effects particularly due to their interference
with redox balance [5].
Therefore, advanced and innovative studies of natural
product interactions with human metabolism are warranted.
The diversity of natural products should be the advantage in
our search for the best anticancer nature-inspired drugs.
This special issue assembles twelve contributions (three
reviews and nine original articles) regarding the anticancer
effects of different natural products and their derivatives, par-
ticularly those with the potential to modulate oxidative-stress
in cancer.
A review article by J. T. de Giffoni de Carvalho et al.
explores medicinal plants found in the Brazilian Cerrado
tropical savanna ecoregion emphasizing the antioxidant
properties of their extracts as well as their potential for cell
death induction in different malignant cells. Moreover, the
authors comprehensively describe other medicinal plants
from the same region which showed protective capacity
against chemotherapy-induced cell toxicity.
Another review article by P. Aiello et al. comprehensively
investigates medicinal plants in the prevention and treatment
of colon cancer. Their study revealed that grape, soybean,
green tea, garlic, olive, and pomegranate are the most effec-
tive plants against colon cancer. Diverse in vitro and in vivo
models provided evidence that fruits, seeds, leaves, and roots
of these plants are abundant in saponins, polysaccharides,
triterpenoids, alkaloids, polyphenol glycosides, including fla-
vonoids, and simple phenols, such as caffeic acid, catechins,
quercetin and luteolin, and kaempferol and luteolin glyco-
sides. These natural compounds exert various effects such
as induction of superoxide dismutase, reduction of DNA oxi-
dation, cell cycle arrest in S phase, suppression of prosurvival
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signaling pathways and cell invasion, reduction of antiapop-
totic and increase of proapoptotic factors, and decrease of
proliferating cell nuclear antigen (PCNA), cyclin A, cyclin
D1, cyclin B1, and cyclin E.
An interesting overview of melatonin protective action
against the side effects of chemotherapy is given by Z. Ma
et al. Melatonin easily crosses all biological barriers while its
concentration within the cells is particularly high in mito-
chondria. This is important for its ability to resist mitochon-
drial oxidative-stress damage. In cancer as well as in other
aging-related diseases, melatonin can reduce mitochondrial-
mediated cell death and thus protect normal cells against the
harmful effects of anthracyclines, alkylating agents, platinum
compounds, antimetabolites, mitotic inhibitors, and novel
targeted therapies.
The remaining original articles are focused on already
isolated and identified natural compounds or plant extracts
tested for their anticancer effects and protective effects
against classic chemotherapy in different cancer models.
D. T. H. Castro et al. investigated antimelanoma effects
of ethanolic extract of Senna velutina roots shown to contain
flavonoid derivatives of the catechin, anthraquinone, and
piceatannol groups. B16F10-Nex2 murine cell line was
used for the assessment of extract’s effects. Results showed
that the extract induced apoptotic cell death followed by
caspase-3 activation and increased intracellular calcium and
ROS levels. Tumor volume and pulmonary metastasis were
followed after subcutaneous implantation of B16F10-Nex2
cells in the lumbosacral region of C57Bl/6 mice. Importantly,
it was shown that both the primary tumor volume and the
number of pulmonary nodules decreased over 50% when this
ethanolic extract was applied.
H. P. Vasantha Rupasinghe et al. showed that the applica-
tion of a bioconversion process using probiotic bacteria Lacto-
bacillus rhamnosus can enhance the pharmacological activities
of cranberry extracts probably by generating more active
metabolites. The proanthocyanidin-rich extract exposed to
the bacteria was particularly active against HepG2 cells induc-
ing significantly stronger mitochondria-dependent apoptosis
when compared to parental extract which was not exposed
to probiotic bacteria.
M. Shen et al. showed both in vitro and in vivo that
betulinic acid induces ROS-dependent apoptosis by inhi-
biting the NF-κB pathway in human multiple myeloma.
Betulinic acid exerted its effect mainly through mitochon-
drial apoptosis induction, cell cycle blockade, mitochon-
drial membrane potential disruption, intracellular ROS
accumulation, and NF-κB signaling inhibition. This com-
prehensive study above all elucidated the complex regula-
tory interaction between ROS and the NF-κB pathway in
multiple myeloma.
E. Hernández-SanMiguel et al. found that Ocoxin® oral
solution affects stem cell properties in certain primary glio-
blastoma cells by inhibiting their self-renewal capacity.
Moreover, systemic treatment of animals bearing heterotopic
and orthotopic xenografts with Ocoxin® reduced tumor bur-
den. Importantly, Ocoxin® exerted a direct effect on macro-
phage polarization in vitro and in vivo, inhibiting the
protumoral features of M2 macrophages.
T. Kowalczyk et al. studied protective antioxidant and anti-
inflammatory properties of aqueous methanolic extracts
derived from the aerial parts and roots of in vitro grown
Menyanthes trifoliata L. plants on human umbilical vein endo-
thelial cells. The authors found that both extracts demonstrated
protective effects against mitochondrial and nuclear DNA
damage caused by ROS. Due to the higher content of selected
phenolic compounds and betulinic acid in the root extract, it
exerted stronger effects than the extract from the aerial part.
G. Isani et al. renewed the interest for the traditional Chi-
nese medicinal plant Artemisia annua L. from which famous
antimalarial drug artemisinin was isolated. The authors
showed that both artemisinin and hydroalcoholic plant
extract induced a cytotoxic effect in D-17 canine osteosar-
coma cells. Pure artemisinin caused an increase of cells in
the S phase, whereas the hydroalcoholic extract induced
G2/M arrest. A significant decrease of iron concentration
was also observed indicating that ferroptosis as a specific cell
death type might contribute to the artemisinin effect. The
hydroalcoholic extract was more potent than pure artemisi-
nin demonstrating a possible synergistic effect of its other
components with artemisinin.
D. Pang et al. provided the evidence that polyphyllin VII
isolated from Paris polyphylla var. yunnanensis induces apo-
ptosis and autophagic cell death via ROS-provoked suppres-
sion of AKT/mTORC1 signaling cascade. Moreover,
polyphyllin VII in combination with temozolomide showed
synergistic interaction followed by a decrease of MGMT
expression. Therefore, polyphyllin VII can be considered as
a valuable drug to attenuate the ability of glioma cells to
repair the temozolomide-induced DNA methylation and
reduce the resistance to temozolomide.
I. Kumburovic et al. showed that anxiogenic manifesta-
tion of widely used chemotherapeutic cisplatin caused by
increased oxidative stress and proapoptotic effect in the hip-
pocampus can be attenuated by supplementation with
Satureja hortensis L. methanolic extract in rats. This work
suggests a beneficial role of these natural products in the pro-
tection of cisplatin-induced neurotoxicity.
B. Yang et al. demonstrated that tetramethylpyrazine, an
alkaloid extracted from the roots of Ligusticum chuanxiong
Hort, can overcome doxorubicin-induced endothelian toxic-
ity. To that end, the authors used vascular endothelium
injury models in mice and human umbilical vein endothelial
cells and showed that tetramethylpyrazine protects the vas-
cular endothelium against doxorubicin-induced injury via
upregulating 14-3-3γ expression, promoting translocation
of Bcl-2 to the mitochondria, closing mitochondria perme-
ability transition pore, maintaining mitochondrial mem-
brane potential, and suppressing oxidative stress.
Overall, the articles presented in this special issue provide
experimental evidence and assembled scientific data, which
clearly emphasize the medicinal value of natural products
to fight cancer and prevent side effects of approved chemo-
therapeutics by modulating oxidative stress. Our planet has
to offer plenty of bioactive molecules of which some are not
yet discovered, and this raises the hope that in the future
we will be able to sustainably exploit natural resources and
find more potent and safer anticancer agents.
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